Back
Ribbon Communications Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
41
RBBN
Ribbon Communications
Last Price:
3.27
Seasonality Move:
-6.55%
Sell
26
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
41
Ribbon Communications (RBBN)
is a Sell
Is Ribbon Communications a Buy, Sell or Hold?
- The current Ribbon Communications [RBBN] share price is $3.24. The Score for RBBN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- RBBN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $55.20. The Score for RARE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RBBN Stock Price Chart
What is Ribbon Communications's stock price today?
-
The Ribbon Communications share price today is $3.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RBBN is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $55.20
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
RBBN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 57.06 | Buy |
Chaikin Money Flow: | -45482 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.95 - 3.29) | Buy |
Bollinger Bands (100): | (2.94 - 3.44) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 46.4 | Sell |
Chaikin Money Flow: | -343486 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.94 - 58.24) | Sell |
Bollinger Bands (100): | (40.06 - 53.94) | Buy |
RBBN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.09 | Buy |
20-day SMA: | 3.07 | Buy |
50-day SMA: | 3.18 | Buy |
200-day SMA: | 3.08 | Buy |
8-day EMA: | 3.12 | Buy |
20-day EMA: | 3.1 | Buy |
50-day EMA: | 3.14 | Buy |
200-day EMA: | 3.07 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.58 | Sell |
20-day SMA: | 57.08 | Sell |
50-day SMA: | 52.76 | Buy |
200-day SMA: | 46.81 | Buy |
8-day EMA: | 57.09 | Sell |
20-day EMA: | 56.67 | Sell |
50-day EMA: | 53.36 | Buy |
200-day EMA: | 47.25 | Buy |
Ribbon Communications Earnings Growth & RBBN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.04 per share, and an increase next year of $0.07 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Ribbon Communications Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |